People with hematologic malignancies—or blood cancers including leukemia, lymphoma, and multiple myeloma—have an impaired immune system due to their disease and its treatment, putting them at risk of severe COVID-19 infection ...
Jul 11, 2022
0
3
COVID vaccination is highly protective against severe disease in people of all body weights, new British research finds.
Jul 5, 2022
0
6
A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing ...
Jun 27, 2022
0
59
Moderna is seeking authorization from the U.S. Food and Drug Administration for a COVID-19 vaccine that adds protection specifically against the omicron variant of the coronavirus.
Jun 14, 2022
0
13
French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.
Jun 13, 2022
0
7
With COVID-19 cases rising again in the Bay Area, parents have a new consideration for protecting their children this week: The Food and Drug Administration granted emergency use authorization Tuesday for kids ages 5-11 to ...
May 19, 2022
0
1
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Apr 18, 2022
0
133
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Apr 14, 2022
0
5
The Biden administration is planning to give Americans age 50 or older the option of a second booster. But is a second booster necessary? Would it differ from the first booster? And who should receive the second booster first?
Mar 29, 2022
0
11
The European Union's drug regulator said Tuesday it has begun an accelerated review process for an experimental coronavirus vaccine booster made by the Spanish company Hipra.
Mar 29, 2022
0
5
